Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
27.33
+0.41 (1.52%)
At close: Aug 3, 2026, 4:00 PM EDT
28.17
+0.84 (3.07%)
Pre-market: Aug 4, 2026, 4:07 AM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.51 billion as of August 4, 2026. Its market cap has increased by 131.79% in one year.
Market Cap
1.51B
Enterprise Value
1.22B
1-Year Change
131.79%
Ranking
Category
Stock Price
$27.33
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.51B, an increase of 120.74%. That is a compound annual growth rate of 69.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.51B | -24.13% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.59B |
| AnaptysBio | 1.58B |
| Zymeworks | 1.57B |
| Sarepta Therapeutics | 1.57B |
| Septerna | 1.55B |
| Innoviva | 1.55B |
| First Tracks Biotherapeutics | 1.54B |
| MoonLake Immunotherapeutics | 1.52B |